Join us with our guests from Seres Therapeutics as they discuss the latest news
on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C.

Join us with our guests from Seres Therapeutics as they discuss the latest news on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C.

Topline Data on SER-109 Efficacy & Safety From T/ECOSPORIII Trial

“C. diff. Spores and More” is an educational program providing you with up-to-date information pertaining to C. diff. and Healthcare-Associated infections. Raising awareness through education and advocacy saves lives worldwide. Topics are of C. difficile infection (CDI) prevention, treatments, and environmental safety products along with Healthcare-Associated Infection (HAI) awareness and more. Our guests are topic experts discussing Antibiotic Resistance, Research and Development, Clinical trials, Nutrition Counseling, Microbiome, Mental health, C. diff. survivors, and so much more. Please join us every Tuesday at 10 AM Pacific Time on the VoiceAmerica Health and Wellness Channel.

Share Topline Data on SER-109 Efficacy & Safety From T/ECOSPORIII Trial

Sign up to save your podcasts

Topline Data on SER-109 Efficacy & Safety From T/ECOSPORIII Trial

Topline Data on SER-109 Efficacy & Safety From T/ECOSPORIII Trial

More shows like C. diff. Spores and More

Breaking Banks

Getting In: A College Coach Conversation

Express Yourself!

Optimal Health Daily - Fitness and Nutrition

The Soul of Enterprise: Business in the Transformation Economy by THRESHOLD

Civil War Talk Radio

The Dr. Hyman Show

The Sexy Lifestyle with Carol and David

Cat Talk Radio

Fearlessly Authentic

Functional Medicine

Men’s Therapy Podcast